目的: 探讨降钙素原、D-二聚体、N-末端脑钠肽前体(NT-proBNP)对重度慢性阻塞性肺疾病急性加重期(acute exacerbation of chronic obstructive pulmonary disease, AECOPD)患者预后的意义。方法: 回顾性分析102例重度AECOPD的临床资料。根据患者预后情况分为预后不良组(36例)和预后良好组(66例),检测对比两组的降钙素原、D-二聚体和NT-proBNP,采用logistic回归分析进行多因素分析,并以ROC曲线评价预后预测价值。结果: 预后不良组降钙素原、D-二聚体、NT-proBNP的浓度均明显高于预后良好组(P＜0.01)。降钙素原、D-二聚体和NT-proBNP在logistic回归分析中的P值均＜0.05。降钙素原、D-二聚体和NT-proBNP的AUC分别为0.743、0.778、0.708(P＜0.01)。降钙素原联合D-二聚体、降钙素原联合NT-proBNP、D-二聚体联合NT-proBNP的 AUC分别为0.847、0.815和0.798(P＜0.01)。3项指标联合检测的AUC为0.862(P＜0.01)。结论: 降钙素原、D-二聚体和NT-proBNP均是重度AECOPD预后不良的独立危险因素,并在重度AECOPD预后预测中均有一定的价值,其中三者联合检测的预后预测效能最高。
Objective: To investigate the Prognostic significance of procalcitonin, D-dimer and N-terminal pro-brain natriuretic peptide (NT-proBNP) in patients with severe acute exacerbation of chronic obstructive pulmonary disease (AECOPD). Methods: The clinical data of 102 patients with severe AECOPD were analyzed retrospectively. The patients were divided into poor prognosis group (36 cases) and good prognosis group (66 cases) based on different prognoses. The procalcitonin, D-dimer and NT-proBNP were detected and compared between the two groups. Logistic regression analysis was used for multivariate analysis and ROC curve was used to evaluate the prognostic value. Results: The concentrations of procalcitonin, D-dimer and NT-proBNP in the poor prognosis group were significantly higher than those in the good prognosis group (P＜0.01). The P values of procalcitonin, D-dimer and NT-proBNP in logistic regression analysis were all lower than 0.05. AUC of procalcitonin, D-dimer and NT proBNP were 0.743, 0.778 and 0.708 respectively (P＜0.01). AUC of procalcitonin combined with D-dimer, procalcitonin combined with NT-proBNP, D-dimer combined with NT proBNP were 0.847, 0.815 and 0.798, respectively (P＜0.01). The AUC of Joint testing of three indicators was 0.862 (P＜0.01). Conclusion: Procalcitonin, D-dimer and NT-proBNP are independent risk factors for poor prognosis of severe AECOPD, which have certain predicting value in the prognosis of severe AECOPD, and the combined detection of the three could achieve the best prognostic effect.
[1] Chen L, Chen LJ, Zheng H, et al. Emergency admission parameters for predicting in-hospital mortality in patients with acute exacerbations of chronic obstructive pulmonary disease with hypercapnic respiratory failure[J]. BMC Pulm Med, 2021, 21(1): 258.
[2] Choi JJ, Mccarthy MW. Novel applications for serum procalcitonin testing in clinical practice[J]. Expert Rev Mol Diagn, 2018, 18(1): 27-34.
[3] 安铁峰, 谢苗荣, 王文科, 等. 血清肾上腺髓质素原、降钙素原、D-二聚体水平对急诊慢性阻塞性肺疾病急性加重并Ⅱ型呼吸衰竭患者预后的预测价值[J]. 实用心脑肺血管病杂志, 2019, 27(6): 62-67.
[4] 慢性阻塞性肺疾病急性加重(AECOPD)诊治专家组. 慢性阻塞性肺疾病急性加重(AECOPD)诊治中国专家共识(2014年修订版)[J]. 国际呼吸杂志, 2014, 34(1): 1-11.
[5] 周璇, 杨万春, 王勇生, 等. 慢性阻塞性肺疾病急性加重期患者血清PCT、hs-CRP、D-D和FIB与肺功能和预后的关系研究[J]. 现代生物医学进展, 2020, 20(16): 3168-3137.
[6] 包东亮, 谢清, 王莲. 血清PCT、D-D及BNP水平与AECOPD合并呼吸衰竭患者病情严重程度的相关性[J]. 标记免疫分析与临床, 2020, 27(2): 288-292.
[7] Bai YF, Lu J, Cheng Y, et al. NF-кB increases LPS-mediated procalcitonin production in human hepatocytes[J]. Sci Rep, 2018, 8(1): 8913.
[8] Le YJ, Chen TE, Xun K, et al. Expression of the long intergenic non-coding RNA (lincRNA) of the NED25 gene modulates the microRNA-125b, STAT3, nitric oxide, and procalcitonin signaling pathways in patients with Sepsis[J]. Med Sci Monit, 2018, 24: 4555-4566.
[9] Yan XD, Li WQ, Yang LY, et al. MiR-135a protects vascular endothelial cells against ventilator-induced lung injury by inhibiting PHLPP2 to activate PI3K/Akt pathway[J]. Cell Physiol Biochem, 2018, 48(3): 1245-1258.
[10] Boonyarittipong M, Kurathong S, Trakarnvanich T. Interleukin-6, procalcitonin, and vascular endothelial growth factor in plasma and dialysate correlate with dialysis adequacy in continuous ambulatory peritoneal dialysis patients[J]. Clin Nephrol, 2019, 92(5): 273-275.
[11] Chen K, Pleasants KA, Pleasants RA, et al. Procalcitonin for antibiotic prescription in chronic obstructive pulmonary disease exacerbations: systematic review, meta-analysis, and clinical perspective[J]. Pulm Ther, 2020, 6(2): 201-214.
[12] Borsi H, Nia EP, Mal-amir MD, et al. Relationship between serum procalcitonin level and chronic obstructive pulmonary disease[J]. J Family Med Prim Care, 2019, 8(2): 738-740.
[13] 邹奇, 瞿明奎, 杜斌, 等. 重症慢性阻塞性肺疾病急性加重期患者血清降钙素原、超敏C反应蛋白和D-二聚体水平变化及意义[J]. 中国基层医药, 2018, 25(23): 3082-3085.
[14] Glober N, Tainter CR, Brennan J, et al. Use of the d-dimer for detecting pulmonary embolism in the emergency department[J]. J Emerg Med, 2018, 54(5): 585-592.
[15] Nickel CH, Kellett J, Cooksley T, et al. The diagnoses and outcomes of emergency patients with an elevated D-dimer over the next 90 days[J]. Am J Med, 2021, 134(2): 260-266.
[16] 蔡秋妍, 陈璟. 老年慢性肺源性心脏病合并心力衰竭急性加重期患者血清NT-pro-BNP和降钙素原水平及意义[J]. 中国急救复苏与灾害医学杂志, 2020, 15(5): 519-522.
[17] 刘颜岗, 索文莉, 王倩, 等. 血清PCT、D-D、NT-proBNP及白细胞水平对社区获得性肺炎患者的临床意义[J]. 宁夏医科大学学报, 2021, 43(7): 677-681.
[18] 金午仙, 叶丹, 王学静. 血浆NT-pro BNP和hs-CRP在COPD合并呼吸衰竭中的临床价值[J]. 河北医药, 2019, 41(11): 1696-1702.
[19] 夏申宏, 邵璐, 朱志勇, 等. 氨基末端脑钠肽前体在慢性阻塞性肺疾病患者中的变化及与病情严重程度的相关性分析[J]. 实用医院临床杂志, 2020, 17(6): 37-40.
